Susquehanna International Group’s Akoya BioSciences AKYA Stock Holding History

Susquehanna International Group’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,500	Closed	-$31.3K	–	12572
2025 Q1	$31.3K	Hold	22,500	–	–	﹤0.01%	11993
2024 Q4	$51.5K	Buy	+22,500	New	+$59.6K	﹤0.01%	11660
2024 Q3	–	Sell	-61,300	Closed	-$143K	–	11876
2024 Q2	$143K	Sell	61,300 -2,600	-4%	-$8.29K	﹤0.01%	10738
2024 Q1	$300K	Buy	63,900 +37,000	+138%	+$192K	﹤0.01%	9690
2023 Q4	$131K	Buy	26,900 +4,600	+21%	+$19.1K	﹤0.01%	11094
2023 Q3	$104K	Buy	+22,300	New	+$128K	﹤0.01%	10883
2022 Q4	–	Sell	-262,800	Closed	-$3.09M	–	12300
2022 Q3	$3.09M	Buy	262,800 +211,600	+413%	+$2.79M	﹤0.01%	4024
2022 Q2	$658K	Buy	+51,200	New	+$531K	﹤0.01%	7594

Susquehanna International Group's AKYA Position: Q3 2025 in Review

Susquehanna International Group sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 176,961 shares — an estimated $230K sold.

Susquehanna International Group first reported a position in AKYA in Q4 2022 and held it in 7 quarters. The position peaked at $876K in Q4 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Susquehanna International Group reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 176,961 Akoya BioSciences shares in Q3 2025, an estimated $230K.
Susquehanna International Group first reported a position in Akoya BioSciences in Q4 2022 and held it in 7 quarters.
Susquehanna International Group's Akoya BioSciences position peaked at $876K in Q4 2022.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.